Caprolactam Chemicals Intrinsic Value
Caprolactam Chemicals (CAPRO) median intrinsic value is ₹14.40 from 9 valuation models (range ₹10–₹54), vs current price ₹47.06 — -69.4% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse CAPRO balance sheet details for revenue, profit, balance sheet and cash flow data.
CAPRO Valuation Methods Summary — DCF, Graham Number & P/E
Caprolactam Chemicals intrinsic value across 9 models vs current price ₹47.06 — upside/downside and value range per method. Also explore CAPRO price trends to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹14.12 | ₹11.30 - ₹16.94 | -70.0% | EPS: ₹1.00, Sector P/E: 12x |
| Book Value Method | asset | ₹10.00 | ₹9.00 - ₹11.00 | -78.8% | Book Value/Share: ₹10.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹14.40 | ₹12.96 - ₹15.84 | -69.4% | Revenue/Share: ₹18.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹36.00 | ₹32.40 - ₹39.60 | -23.5% | EBITDA: ₹3.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹54.33 | ₹43.46 - ₹65.20 | +15.4% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹14.12 | ₹12.71 - ₹15.53 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹14.12 | ₹12.71 - ₹15.53 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹28.00 | ₹25.20 - ₹30.80 | -40.5% | ROE: 20.0%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹15.00 | ₹13.50 - ₹16.50 | -68.1% | EPS: ₹1.00, BVPS: ₹10.00 |
CAPRO Intrinsic Value vs Market Price — All Valuation Models
Caprolactam Chemicals fair value range ₹10–₹54 vs current market price ₹47.06 across 9 valuation models. For current market price and key ratios, visit Caprolactam Chemicals stock price NSE.
CAPRO Intrinsic Value Analysis — Undervalued or Overvalued?
Caprolactam Chemicals median intrinsic value ₹14.40, current price ₹47.06 — Trading Above Calculated Value by 69.4%, margin of safety -100.0%.
What is the intrinsic value of CAPRO?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Caprolactam Chemicals (CAPRO) is ₹14.40 (median value). With the current market price of ₹47.06, this represents a -69.4% variance from our estimated fair value.
The valuation range spans from ₹10.00 to ₹54.33, indicating ₹10.00 - ₹54.33.
Is CAPRO undervalued or overvalued?
Based on our multi-method analysis, Caprolactam Chemicals (CAPRO) appears to be trading above calculated value by approximately 69.4%.
CAPRO Financial Health — Key Ratios vs Industry Benchmarks
Caprolactam Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 20.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 32.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.64x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CAPRO Cash Flow Quality — Operating & Free Cash Flow
Caprolactam Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-1 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹1 Cr | ₹0 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹3 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |